Focus: Bioiberica is a 5,000+ employee biotechnology company headquartered in Barcelona, Spain, founded in 1975, specializing in heparin science, healthcare, companion animal health, animal nutrition, and plant health. As a public company, it operates across multiple therapeutic areas including gastroenterology and neurology.
Profile data last refreshed 18h ago · AI intelligence enriched 2w ago
No open roles listed right now. Follow Bioiberica to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Bioiberica's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Bioiberica
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
CPHI Milan 2026: Bioiberica eyes longevity and GLP-1 as healthy aging becomes targeted - Nutrition Insight
CPHI Milan 2026: Bioiberica eyes longevity and GLP-1 as healthy aging becomes targeted Nutrition Insight
Bioiberica spotlights heparin research pipeline and traceable ingredients at CPHI Milan - Nutraceutical Business Review
Bioiberica spotlights heparin research pipeline and traceable ingredients at CPHI Milan Nutraceutical Business Review
Chondroitin Sulfate Market (2026-2033) | Osteoarthritis, - openPR.com
Chondroitin Sulfate Market (2026-2033) | Osteoarthritis, openPR.com
No open positions listed yet. Check their careers page directly.
Recent peer-reviewed publications with author affiliations at this company
Dietary nucleotide supplementation attenuates disease severity and modulates clinicopathological responses in lambs with neonatal diarrhea syndrome.
Specific monitoring of viable plant growth-promoting Bacillus velezensis PH-023 in the rhizosphere of tomato.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo